Paper36923407
Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.
Zhong H and 11 others. Front Immunol, 2023. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer. Papers, record 36923407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923407
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Humans | |
| Biomarkers | |
| Databases, Protein | |
| DNA Copy Number Variations | |
| Prognosis | |
| Cell Cycle Proteins |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38868713 | Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. | Imeta | 2022 | https://conductscience.org/library/papers/38868713 | PubMed |
| 2 | 32457745 | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies. | Front Immunol | 2020 | https://conductscience.org/library/papers/32457745 | PubMed |
| 3 | 34304958 | Cell cycle on the crossroad of tumorigenesis and cancer therapy. | Trends Cell Biol | 2022 | https://conductscience.org/library/papers/34304958 | PubMed |
| 4 | 33811125 | Therapeutic Targeting of the Tumor Microenvironment. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33811125 | PubMed |
| 5 | 34879798 | Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid. | Curr Drug Targets | 2022 | https://conductscience.org/library/papers/34879798 | PubMed |
| 6 | 30903160 | TISIDB: an integrated repository portal for tumor-immune system interactions. | Bioinformatics | 2019 | https://conductscience.org/library/papers/30903160 | PubMed |
| 7 | 16361640 | Targeting the cell cycle: a new approach to cancer therapy. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/16361640 | PubMed |
| 8 | 31962285 | Cancer immunotherapy: Pros, cons and beyond. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/31962285 | PubMed |
| 9 | 32000802 | Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32000802 | PubMed |
| 10 | 29790900 | GSCALite: a web server for gene set cancer analysis. | Bioinformatics | 2018 | https://conductscience.org/library/papers/29790900 | PubMed |
| 11 | 28596308 | Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. | Science | 2017 | https://conductscience.org/library/papers/28596308 | PubMed |
| 12 | 17499476 | Characterization of the FAM110 gene family. | Genomics | 2007 | https://conductscience.org/library/papers/17499476 | PubMed |
| 13 | 31350295 | The Tumor Microenvironment Innately Modulates Cancer Progression. | Cancer Res | 2019 | https://conductscience.org/library/papers/31350295 | PubMed |
| 14 | 30730277 | Enhancing tumor T cell infiltration to enable cancer immunotherapy. | Immunotherapy | 2019 | https://conductscience.org/library/papers/30730277 | PubMed |
| 15 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
| 16 | 34080749 | CK1-mediated phosphorylation of FAM110A promotes its interaction with mitotic spindle and controls chromosomal alignment. | EMBO Rep | 2021 | https://conductscience.org/library/papers/34080749 | PubMed |
| 17 | 29092952 | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092952 | PubMed |
| 18 | 33125859 | The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. | Cancer Cell | 2021 | https://conductscience.org/library/papers/33125859 | PubMed |
| 19 | 32289269 | Acquired Resistance to Immune Checkpoint Inhibitors. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32289269 | PubMed |
| 20 | 29669262 | DNA mismatch repair in cancer. | Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29669262 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42495610 | C17orf75 (Njmu-R1) promotes hepatocellular carcinoma progression: a pan-cancer analysis and experimental validation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42495610 | PubMed |
| 42042880 | Integrative Multi-Omics Analysis Reveals HNRNPLL as a Potential Biomarker Associated with Hepatocellular Carcinoma Progression. | Metabolites | 2026 | https://conductscience.org/library/papers/42042880 | PubMed |
| 41700295 | Mitophagy-related molecular signatures in ulcerative colitis revealed by machine learning and molecular dynamics. | Front Genet | 2026 | https://conductscience.org/library/papers/41700295 | PubMed |
| 41674941 | Multi-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancers. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41674941 | PubMed |
| 41577841 | Comprehensive review of publicly accessible databases for gastrointestinal cancer and future challenges in database construction. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41577841 | PubMed |
| 41469676 | Lactate-related biomarkers in severe acute pancreatitis: insights from machine learning, molecular dynamics, and experimental validation. | J Biol Eng | 2025 | https://conductscience.org/library/papers/41469676 | PubMed |
| 41234880 | Molecular dynamics simulation and single-cell and spatial transcriptomics validate immune and prognostic biomarkers in colorectal cancer and construct a clinical prognostic model. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41234880 | PubMed |
| 40958861 | Molecular mechanism of LncRNA MALAT1 in regulating hepatocellular carcinoma progression via the miR-383-5p/PRKAG1 axis and its role in the tumor immune microenvironment. | Front Oncol | 2025 | https://conductscience.org/library/papers/40958861 | PubMed |
| 40640749 | Rhein alleviates hepatic steatosis in NAFLD mice by activating the AMPK/ACC/SREBP1 pathway to enhance lipid metabolism. | Mol Med | 2025 | https://conductscience.org/library/papers/40640749 | PubMed |
| 40599718 | Nuclear factor IA-mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression. | Mol Clin Oncol | 2025 | https://conductscience.org/library/papers/40599718 | PubMed |
| 40301429 | Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40301429 | PubMed |
| 40144665 | The role of TRAF2 in pan-cancer revealed by integrating informatics and experimental validation. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40144665 | PubMed |
| 39915534 | Exploring the prognostic role of microbial and genetic markers in lung squamous cell carcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/39915534 | PubMed |
| 39766835 | Exploration of Key Regulatory Factors in Mesenchymal Stem Cell Continuous Osteogenic Differentiation via Transcriptomic Analysis. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39766835 | PubMed |
| 39735331 | CBX3 contributes to pancreatic adenocarcinoma progression via promoting KIF20A expression. | Cytotechnology | 2025 | https://conductscience.org/library/papers/39735331 | PubMed |
| 39462268 | Multi-omics analysis reveals BZW1's regulation of EMT via the Wnt pathway in lung adenocarcinoma. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/39462268 | PubMed |
| 39183260 | A comprehensive prognostic and immune infiltration analysis of UBA1 in pan-cancer: A computational analysis and in vitro experiments. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/39183260 | PubMed |
| 39181933 | Genome-wide identification of copy number variations in wrinkled skin cases of Xiang pigs. | Sci Rep | 2024 | https://conductscience.org/library/papers/39181933 | PubMed |
| 39081276 | Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer. | J Transl Int Med | 2024 | https://conductscience.org/library/papers/39081276 | PubMed |
| 38836983 | Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/38836983 | PubMed |
Genes56
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36923407
GET https://conductscience.org/api/papers/v1/36923407/references?page=2